Improving cancer outcomes and leadership course: an ESO, ECO, SPCC European initiative
07.06.2022 - 09.07.2022
IN PERSON PART IN WARSAW
COURSES AND SEMINARS
Block 2
07.07.2022 - 09.07.2022
Improving cancer outcomes and leadership course: an ESO, ECO & SPCC European initiative - Block 2
Programme
7 July | ||
16:55 | Introduction, Purpose and summary of the course and its goals Yolande Lievens, BE - Razvan Popescu, CH - Pietro Presti, CH | |
17:25 | The European Code of Cancer Practice Mark Lawler, UK - Kathy Oliver, UK - Peter Selby, UK | |
18:10 | Long Term Strategic Approaches to Oncopolicy Richard Sullivan, UK | |
19:00 | Aperitivo & Networking | |
20:00 | Dinner | |
8 July | ||
8:30 | Comparative Healthcare Systems Including Factors Determining Effective and Efficient Cancer Care Ajay Aggarwal, UK | |
9:20 | Value-based Clinical Decision Making Alexandru Eniu, CH | |
10:10 | Coffee & Networking | |
10:40 | Breakout Session 1 | |
12:30 | Lunch & Networking | |
13:30 | Managerial Skills That Will Help You Make A Difference Alexandre Lourenço, PT | |
14:20 | Partnerships with Industry Matti Aapro, CH | |
15:10 | Coffee & Networking | |
15:40 | Breakout Session 2 | |
17:20 | Clinical Leadership for Effective Multidisciplinary Cancer Care Fatima Cardoso, PT | |
19:30 | Dinner | |
9 July | ||
8:30 | The European Actions Against Cancer Piotr Rutkowski, PL | |
9:20 | Improving Efficiency in Cancer Care: Highlights and Best Practices from the SPCC/All.Can/SDA Bocconi Project Matt Hickey, UK | |
10:10 | Coffee & Networking | |
10:40 | Breakout Session 3 | |
12:30 | Lunch & Networking | |
13:30 | Integrating supportive and palliative care into oncology practice to improve patient outcomes Stein Kaasa, NO | |
14:20 | How to explain the benefits of a clinical trial to a patient Andreas Charalambous, CY | |
15:10 | Coffee & Networking | |
15:40 | Breakout Session 4 | |
17:20 | Next steps and Future plans Peter Selby, UK | |
18:10 | Closing remarks Alexandru Eniu, CH | |
19:30 | Evening Free |
Faculty
Matti Aapro, Clinique de Genolier, Dept. of Breast Center, Genolier, CH
Ajay Aggarwal, London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Andreas Charalambous, Cyprus University of Technology , Dept. of Oncology Nursing (Limassol, CY)
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Matt Hickey, The Health Value Alliance, Management dept., Surrey, UK
Stein Kaasa, Oslo University Hospital, Department of Oncology, Oslo, NO
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Yolande Lievens, Ghent University Hospital, Radiation Oncology Dept. Ghent, BE
Alexandre Lourenço, Centro Hospitalar e Universitario de Coimbra, Innovation & Development Unit, Coimbra, PT
Kathy Oliver, International Brain Tumour Alliance - IBTA, Patient Advocacy Dpt., Tadworth, Surrey, UK
Razvan Popescu, Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Pietro Presti, Fondazione Edo & Elvo Tempia, ., Biella, IT
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Peter Selby, University of Leeds/St. James's University Hospital/European Cancer Concord, Dept. of Cancer Research, Leeds, UK
Richard Sullivan, King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK